
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
2020 American College of Rheumatology Guideline for the Management of Gout
John FitzGerald, Nicola Dalbeth, Ted R. Mikuls, et al.
Arthritis Care & Research (2020) Vol. 72, Iss. 6, pp. 744-760
Open Access | Times Cited: 654
John FitzGerald, Nicola Dalbeth, Ted R. Mikuls, et al.
Arthritis Care & Research (2020) Vol. 72, Iss. 6, pp. 744-760
Open Access | Times Cited: 654
Showing 1-25 of 654 citing articles:
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1997
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1997
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Mihai-Emil Gherghina, Ileana Peride, Mirela Ţigliş, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 237
Mihai-Emil Gherghina, Ileana Peride, Mirela Ţigliş, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3188-3188
Open Access | Times Cited: 237
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Yoshitaka Kimura, Daisuke Tsukui, Hajime Kono
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12394-12394
Open Access | Times Cited: 202
Yoshitaka Kimura, Daisuke Tsukui, Hajime Kono
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12394-12394
Open Access | Times Cited: 202
Role of diet in hyperuricemia and gout
Abhijeet Danve, Shiv T. Sehra, Tuhina Neogi
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 4, pp. 101723-101723
Open Access | Times Cited: 143
Abhijeet Danve, Shiv T. Sehra, Tuhina Neogi
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 4, pp. 101723-101723
Open Access | Times Cited: 143
YouTube as a source of information on gout: a quality analysis
Mustafa Erkut Önder, Orhan Zengin
Rheumatology International (2021)
Open Access | Times Cited: 111
Mustafa Erkut Önder, Orhan Zengin
Rheumatology International (2021)
Open Access | Times Cited: 111
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 90
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 90
Trends in Prevalence of Gout Among US Asian Adults, 2011-2018
Chio Yokose, Natalie McCormick, Na Lu, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e239501-e239501
Open Access | Times Cited: 52
Chio Yokose, Natalie McCormick, Na Lu, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e239501-e239501
Open Access | Times Cited: 52
Global, Regional, and National Prevalence of Gout From 1990 to 2019: Age-Period-Cohort Analysis With Future Burden Prediction
Qiyu He, Tsz‐Ngai Mok, Tat‐Hang Sin, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e45943-e45943
Open Access | Times Cited: 49
Qiyu He, Tsz‐Ngai Mok, Tat‐Hang Sin, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e45943-e45943
Open Access | Times Cited: 49
Mechanisms and rationale for uricase use in patients with gout
Naomi Schlesinger, Fernando Perez‐Ruiz, Frédéric Lioté
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 10, pp. 640-649
Closed Access | Times Cited: 46
Naomi Schlesinger, Fernando Perez‐Ruiz, Frédéric Lioté
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 10, pp. 640-649
Closed Access | Times Cited: 46
Serum Urate and Recurrent Gout
Natalie McCormick, Chio Yokose, Gregory J. Challener, et al.
JAMA (2024) Vol. 331, Iss. 5, pp. 417-417
Open Access | Times Cited: 22
Natalie McCormick, Chio Yokose, Gregory J. Challener, et al.
JAMA (2024) Vol. 331, Iss. 5, pp. 417-417
Open Access | Times Cited: 22
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 17
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 17
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Vicente E. Torres, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. 234-254
Open Access | Times Cited: 7
Vicente E. Torres, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. 234-254
Open Access | Times Cited: 7
KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Olivier Devuyst, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. S1-S239
Open Access | Times Cited: 6
Olivier Devuyst, Curie Ahn, Thijs R.M. Barten, et al.
Kidney International (2025) Vol. 107, Iss. 2, pp. S1-S239
Open Access | Times Cited: 6
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
И. И. Дедов, Marina V. Shestakova, G. А. Melnichenko, et al.
Obesity and metabolism (2021) Vol. 18, Iss. 1, pp. 5-99
Open Access | Times Cited: 98
И. И. Дедов, Marina V. Shestakova, G. А. Melnichenko, et al.
Obesity and metabolism (2021) Vol. 18, Iss. 1, pp. 5-99
Open Access | Times Cited: 98
Pathophysiology of hyperuricemia and its clinical significance – a narrative review
Marta Skoczyńska, Małgorzata Chowaniec, Maciej Szymczak, et al.
Reumatologia/Rheumatology (2020) Vol. 58, Iss. 5, pp. 312-323
Open Access | Times Cited: 76
Marta Skoczyńska, Małgorzata Chowaniec, Maciej Szymczak, et al.
Reumatologia/Rheumatology (2020) Vol. 58, Iss. 5, pp. 312-323
Open Access | Times Cited: 76
Autoinflammatory Features in Gouty Arthritis
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1880-1880
Open Access | Times Cited: 76
Paola Galozzi, Sara Bindoli, Andrea Doria, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1880-1880
Open Access | Times Cited: 76
Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights
Yongsheng Mei, Bingzi Dong, Zhuang Geng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 67
Yongsheng Mei, Bingzi Dong, Zhuang Geng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 67
Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 62
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 62
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities
Lisa K. Stamp, Hamish Farquhar, Huai Leng Pisaniello, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 633-641
Open Access | Times Cited: 60
Lisa K. Stamp, Hamish Farquhar, Huai Leng Pisaniello, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 10, pp. 633-641
Open Access | Times Cited: 60
Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management
James R. O’Dell, Mary T. Brophy, Michael H. Pillinger, et al.
NEJM Evidence (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 57
James R. O’Dell, Mary T. Brophy, Michael H. Pillinger, et al.
NEJM Evidence (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 57
Association between nutrient patterns and hyperuricemia: mediation analysis involving obesity indicators in the NHANES
Juping Wang, Shuting Chen, Junkang Zhao, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 45
Juping Wang, Shuting Chen, Junkang Zhao, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 45
Recent advances in gout drugs
Cheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114890-114890
Closed Access | Times Cited: 45
Cheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114890-114890
Closed Access | Times Cited: 45
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases
Masanari Kuwabara, Tomoko Fukuuchi, Yuhei Aoki, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1519-1519
Open Access | Times Cited: 34
Masanari Kuwabara, Tomoko Fukuuchi, Yuhei Aoki, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1519-1519
Open Access | Times Cited: 34
Hyperuricemia: A key contributor to endothelial dysfunction in cardiovascular diseases
Xin Wei, Mao Zhang, Shian Huang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 7
Closed Access | Times Cited: 31
Xin Wei, Mao Zhang, Shian Huang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 7
Closed Access | Times Cited: 31
A review on gout: Looking back and looking ahead
Haolin Tao, Yingshi Mo, Wenbin Liu, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109977-109977
Closed Access | Times Cited: 30
Haolin Tao, Yingshi Mo, Wenbin Liu, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109977-109977
Closed Access | Times Cited: 30